Page results
-
You can get your COVID-19 vaccine this weekend at venues across London
-
This page explains what you can expect before, during and after your treatment in chemotherapy daycare.
-
This information is for patients who are having radiotherapy for a base of skull tumour. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
This booklet explains what stem cells are and how they are collected from your blood. It includes information about what happens before, during and after the collection, and how the cells are stored.
-
GP portal (now called EpicCare Link UCLH) allows GPs to access information about patients they have referred to UCLH.
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
This information explains what alpha thalassaemia is, and provides information about the different types of alpha thalassaemia.
-
Waldenström’s macroglobulinaemia is a rare form of lymphoma (a type of bone marrow cancer), treated at UCLH.
-
We are making it easier and safer for patients to be seen in an Emergency Department (ED) or Accident and Emergency (A&E) department without waiting for long periods of time.
-
Information about community sickle cell and thalassaemia services provided via UCLH.
File results
-
FOI/2024/0132 - Cancer patients diagnosed in A&E
-
FOI/2024/0133 - Non-Emergency Patient Transport Services (NEPTS)
-
FOI/2024/0134 - Joint infection services for paediatric/ adult patients
-
FOI/2024/0136 - Female Genital Mutilation (FGM) cases from 2014-February 2024
-
FOI/2024/0140 - Operations cancelled due to low levels of staffing 2019-2023
-
FOI/2024/0143 - Individuals arriving at A&E not in an ambulance
-
FOI/2024/0144 - Breast cancer treatment
-
FOI/2024/0148 - Cleaning audit system at Trust
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer